Latest news
Cramer’s Analyst Says Eli Lilly’s GLP-1 Stock Rally Has Years Left to Run - BeInCryptoBeInCrypto · Tue, 11 Aug 2026 04:13:00 GMTGan & Lee Pharmaceuticals Hits Daily Limit Up: GLP-1 Drug Licensed to Europe in Deal Worth Up to €664 Million - finance.biggo.comfinance.biggo.com · Tue, 11 Aug 2026 03:36:00 GMTGLP-1 marketing growth, biosimilar competition and China top pharma’s Q2 earnings - Medical Marketing and MediaMedical Marketing and Media · Mon, 10 Aug 2026 21:02:42 GMTAscletis Begins Phase I Studies of Amylin Agonist ASC36 and Its GLP-1/GIP Co-Formulation for Obesity - BioPharm InternationalBioPharm International · Mon, 10 Aug 2026 19:50:09 GMTNew weight-loss pill approved for use in UK - BBCBBC · Mon, 10 Aug 2026 15:25:07 GMTHershey Gathers Consumer Intel to Pinpoint GLP-1 Trends - Consumer Goods TechnologyConsumer Goods Technology · Mon, 10 Aug 2026 14:57:19 GMTCan GLP-1s dull your joy? - The Medical University of South CarolinaThe Medical University of South Carolina · Mon, 10 Aug 2026 13:53:32 GMTFrom GLP-1 hormone to weight-loss drug: How semaglutide is made and why quality matters - theweek.intheweek.in · Mon, 10 Aug 2026 12:37:59 GMT